Brief review on repurposed drugs and vaccines for possible treatment of COVID-19
Author:
Funder
Department of Science and Technology
Publisher
Elsevier BV
Subject
Pharmacology
Reference136 articles.
1. Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza;Abbott;Cell,2020
2. Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms;Adedeji;J. Virol.,2013
3. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses;Adedeji;Antimicrob. Agents Chemother.,2014
4. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs;Anand;Science,2003
5. The proximal origin of SARS-CoV-2;Andersen;Nat. Med.,2020
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proteomics and COVID-19: Recent Trends;Pharmacoproteomics;2024
2. A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19;European Journal of Medicinal Chemistry;2023-11
3. Exploring the potential of FDA approved anti-diabetic drugs for repurposing against COVID-19: a core combination of multiple computational strategies and integrated artificial intelligence;Journal of Biomolecular Structure and Dynamics;2023-07-16
4. Docking Studies and Molecular Dynamics Simulations of Potential Inhibitors from the Brown Seaweed Sargassum polycystum (Phaeophyceae) against PLpro of SARS-CoV-2;BioTech;2023-06-11
5. Combined in silico strategy for repurposing DrugBank entries towards introducing potential anti-SARS-CoV-2 drugs;Canadian Journal of Physiology and Pharmacology;2023-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3